Lavaca Capital’s Allergan plc AGN Stock Holding History

Lavaca Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-15	Closed	-$2K	–	426
2018 Q4	$2K	Buy	+15	New	+$2.46K	﹤0.01%	342

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lavaca Capital's AGN Position: Q1 2019 in Review

Lavaca Capital sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 15 shares — an estimated $2K sold.

Lavaca Capital first reported a position in AGN in Q4 2018 and held it in 1 quarter. The position peaked at $2K in Q4 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

Lavaca Capital reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
Lavaca Capital sold 15 Allergan plc shares in Q1 2019, an estimated $2K.
Lavaca Capital first reported a position in Allergan plc in Q4 2018 and held it in 1 quarter.
Lavaca Capital's Allergan plc position peaked at $2K in Q4 2018.
991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Lavaca Capital's 13F filing for Q1 2019, filed 11 Apr 2019.